Ocular Immunology

Positive topline results from the phase 3 REVEAL-2 trial suggest that elegrobart, an insulin-like growth factor-1 receptor (IGF-1R)-targeting monoclonal antibody developed by Viridian Therapeutics, met its primary endpoint in patients with chronic thyroid eye disease (TED), with both every-four-week (Q4W) and every-eight-week (Q8W) dosing regimens demonstrating statistically significant improvements versus placebo at 24 weeks.

In this Q&A, Dr Berkenstock discusses her decision to pursue ophthalmology, the mentor who shaped her path, and the innovations that excite her most about the future.

As 2025 draws to a close, we’re celebrating another remarkable year of growth, collaboration and innovation at touchOPHTHALMOLOGY. From thought-provoking expert interviews and peer-reviewed research, to dynamic conference coverage and an expanding portfolio of medical education, this year has been ...

In this episode of Visionary Voices, we welcome Associate Professor Grace Vincent from CQUniversity’s Appleton Institute. A leading expert on sleep and shift work, Grace explores how disrupted sleep affects physician health in both the short and long term, as well as its impact on safety and performance. We also discuss what this means for patient outcomes and share practical strategies to manage sleep loss.

A recent study published in the American Journal of Ophthalmology has revealed significant levels of burnout among uveitis specialists in the United States, with 41% of surveyed physicians reporting symptoms of burnout and nearly 50% considered at risk. The cross-sectional survey, distributed through the American Uveitis Society (AUS) and Young Uveitis Society (YUS), used the validated Mini Z 2.0 tool to assess burnout levels.

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

Taking place from 7–9 June 2025 in Lisbon, Portugal, the SOE Congress is one of Europe's leading multi-specialty ophthalmology meetings. With a world-class scientific programme, this in-person event offers a rich mix of symposia, live surgery, debates, workshops, mystery cases and updates ...

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

A recent Phase 2 clinical trial has demonstrated that OCS-05, an innovative treatment for acute optic neuritis (AON), successfully achieved its primary safety endpoint along with secondary efficacy endpoints.